Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan L Roth

Showing results (441-450 of 450) with videos related to

Pageof 45
Sort By:
You have reached the last page of results.This site can display upto 450 results.
Nature|September 28, 2022
Bespoke library docking for 5-HT<sub>2A</sub> receptor agonists with antidepressant activityAnat Levit Kaplan, Danielle N Confair, Kuglae Kim, et al.
Nature Chemical Biology|July 12, 2011
A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cellsMasoud Vedadi, Dalia Barsyte-Lovejoy, Feng Liu, et al.
Nature Structural & Molecular Biology|February 17, 2015
Structural basis for bifunctional peptide recognition at human δ-opioid receptorGustavo Fenalti, Nadia A Zatsepin, Cecilia Betti, et al.
Pharmacological Reviews|December 28, 2020
International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and FunctionNicholas M Barnes, Gerard P Ahern, Carine Becamel, et al.
Nature Reviews. Drug Discovery|February 24, 2018
Unexplored therapeutic opportunities in the human genomeTudor I Oprea, Cristian G Bologa, Søren Brunak, et al.
Nature Reviews. Drug Discovery|March 24, 2018
Unexplored therapeutic opportunities in the human genomeTudor I Oprea, Cristian G Bologa, Søren Brunak, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
<i>De novo</i> design of miniprotein agonists and antagonists targeting G protein-coupled receptorsEdin Muratspahić, David Feldman, David E Kim, et al.
Elife|April 21, 2018
Donated chemical probes for open scienceSusanne Müller, Suzanne Ackloo, Cheryl H Arrowsmith, et al.
Nature|May 21, 2026
De novo design of miniproteins targeting GPCRsEdin Muratspahić, David Feldman, David E Kim, et al.
Nature|May 1, 2020
A SARS-CoV-2 protein interaction map reveals targets for drug repurposingDavid E Gordon, Gwendolyn M Jang, Mehdi Bouhaddou, et al.
Pageof 45

Showing results (441-450 of 450) with videos related to

Sort By:
Pageof 45
You have reached the last page of results.This site can display upto 450 results.
Nature|September 28, 2022
Bespoke library docking for 5-HT<sub>2A</sub> receptor agonists with antidepressant activityAnat Levit Kaplan, Danielle N Confair, Kuglae Kim, et al.
Nature Chemical Biology|July 12, 2011
A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cellsMasoud Vedadi, Dalia Barsyte-Lovejoy, Feng Liu, et al.
Nature Structural & Molecular Biology|February 17, 2015
Structural basis for bifunctional peptide recognition at human δ-opioid receptorGustavo Fenalti, Nadia A Zatsepin, Cecilia Betti, et al.
Pharmacological Reviews|December 28, 2020
International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and FunctionNicholas M Barnes, Gerard P Ahern, Carine Becamel, et al.
Nature Reviews. Drug Discovery|February 24, 2018
Unexplored therapeutic opportunities in the human genomeTudor I Oprea, Cristian G Bologa, Søren Brunak, et al.
Nature Reviews. Drug Discovery|March 24, 2018
Unexplored therapeutic opportunities in the human genomeTudor I Oprea, Cristian G Bologa, Søren Brunak, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
<i>De novo</i> design of miniprotein agonists and antagonists targeting G protein-coupled receptorsEdin Muratspahić, David Feldman, David E Kim, et al.
Elife|April 21, 2018
Donated chemical probes for open scienceSusanne Müller, Suzanne Ackloo, Cheryl H Arrowsmith, et al.
Nature|May 21, 2026
De novo design of miniproteins targeting GPCRsEdin Muratspahić, David Feldman, David E Kim, et al.
Nature|May 1, 2020
A SARS-CoV-2 protein interaction map reveals targets for drug repurposingDavid E Gordon, Gwendolyn M Jang, Mehdi Bouhaddou, et al.
Pageof 45